Tyrx Launched Patient Web Site on EP Device Infection
March 20, 2012 - TyRx Inc. announced the launch of its new patient education website, HeartDeviceInfection.com. It was created to raise awareness ofsurgical site infection associated with cardiac implantable electronic devices (CIEDs) including pacemakers and implantable defibrillators. It also offers information and resources for reducing that risk. It targets patients and caregivers.
“With CIED infections growing much faster than implantations, being very expensive to treat, and having a one-year mortality rate of about 30 percent, it is very important to widely and rapidly educate patients and caregivers that there is technology available that can help prevent these infections,” said TyRx Inc.
“With CIED infections growing much faster than implantations, being very expensive to treat, and having a one-year mortality rate of about 30 percent, it is very important to widely and rapidly educate patients and caregivers that there is technology available that can help prevent these infections," said Charles Kinder, M.D., director, heart rhythm program, Heart Care Centers of Illinois.
By launching HeartDeviceInfection.com, we are able to reach a very broad and diverse audience of patients and caregivers looking for information to address their heart health concerns. HeartDeviceInfection.com will serve as an important resource to help reduce the number of cardiac device infections impacting patients and the heath care system,” said TyRx CEO Robert White.
For more information: www.tyrx.com.
More like this
- Study Results Show Low Infection Rates for CIED Procedures
- TyRx Antibacterial Envelope for Implantable EP Devices Receives Health Canada Approval
- Tyrx Receives Approval for New AigisRx R Fully Resorbable Antibacterial Envelope from Health Canada
- Costs, Mortality Skyrocket Following Infection in Cardiac Device Recipients
- Study Site Enrollment Completed for EP Device Antibacterial Envelope



